Understanding Framingham Risk Score
The Framingham Risk Score (FRS) is a gender-specific algorithm used to estimate the 10-year cardiovascular risk of an individual. It was developed from the Framingham Heart Study, one of the most important epidemiological studies in medical history, which began in 1948.
Framingham Risk Score Categories
| 10-Year CVD Risk | Category | Clinical Recommendation |
|---|---|---|
| < 5% | Low risk | Lifestyle counseling |
| 5–7.4% | Borderline low | Consider lifestyle, reassess |
| 7.5–10% | Borderline | Lifestyle modification; consider statin |
| 10–20% | Intermediate | Statin therapy often recommended |
| > 20% | High risk | Statin + intensive lifestyle changes |
| Notes | ACC/AHA thresholds may differ | Discuss with physician |
Key CVD Risk Factor Reference
| Risk Factor | Low Risk | Borderline | High Risk |
|---|---|---|---|
| Total cholesterol | < 200 mg/dL | 200–239 mg/dL | ≥ 240 mg/dL |
| HDL cholesterol | ≥ 60 mg/dL (protective) | 40–59 mg/dL | < 40 mg/dL (men) / < 50 (women) |
| LDL cholesterol | < 100 mg/dL | 100–159 mg/dL | ≥ 160 mg/dL |
| Systolic blood pressure | < 120 mmHg | 120–129 mmHg | ≥ 130 mmHg |
| Diastolic blood pressure | < 80 mmHg | 80–89 mmHg | ≥ 90 mmHg |
| Fasting glucose | < 100 mg/dL | 100–125 mg/dL | ≥ 126 mg/dL |
| BMI | 18.5–24.9 | 25–29.9 | ≥ 30 |
Major Framingham Study Risk Factor Impact
| Risk Factor | Relative Risk Increase | Notes |
|---|---|---|
| Smoking (current) | 2–4× | Doubles to quadruples CVD risk |
| Hypertension (untreated) | 2–3× | Systolic >160 mmHg |
| Diabetes | 2–4× | Higher in women |
| High LDL | 1.5–3× | Per 40 mg/dL increase |
| Low HDL | 1.5–2× | < 40 mg/dL in men |
| Age (55–65 vs. <45) | 3–5× | Risk increases sharply with age |
| Family history of CHD | 1.5–2× | First-degree relative < 55 (M) / < 65 (F) |
Risk Categories
| 10-Year Risk | Category | Recommendation |
|---|---|---|
| < 10% | Low Risk | Lifestyle modifications, reassess in 5 years |
| 10-20% | Intermediate Risk | Consider additional testing, lifestyle changes |
| > 20% | High Risk | Aggressive risk factor modification, consider statin therapy |
Risk Factors Included
- Age: Risk increases with age
- Sex: Men have higher risk than women at younger ages
- Total Cholesterol: Higher levels increase risk
- HDL Cholesterol: Higher levels are protective
- Systolic Blood Pressure: Higher readings increase risk
- Blood Pressure Treatment: Treated hypertension carries additional risk
- Smoking Status: Current smoking doubles risk
- Diabetes: Significantly increases cardiovascular risk
Modifiable Risk Factors
Blood Pressure Control
Target: Less than 130/80 mmHg for most adults. Achieved through lifestyle changes and medications if needed.
Cholesterol Management
Reduce LDL cholesterol through diet, exercise, and statin therapy when indicated. Increase HDL through exercise and weight loss.
Smoking Cessation
Quitting smoking reduces cardiovascular risk by 50% within one year.
Diabetes Management
Tight glycemic control and management of associated conditions reduce cardiovascular complications.
Limitations
- Derived primarily from white population data
- May underestimate risk in certain ethnic groups
- Does not include family history
- Does not account for inflammatory markers or coronary calcium
- Valid only for ages 30-79 years
- Not applicable for those with existing cardiovascular disease
When to Use This Calculator
The Framingham Risk Score is most useful for:
- Primary prevention assessment
- Deciding whether to initiate statin therapy
- Motivating patients to make lifestyle changes
- Shared decision-making between providers and patients
Medical Disclaimer
This calculator is provided for educational and informational purposes only. It should not be used as a substitute for professional medical advice, diagnosis, or treatment. The Framingham Risk Score is one of many tools used in cardiovascular risk assessment. Treatment decisions should be made in consultation with a healthcare provider who can consider your complete medical history and individual circumstances.
Frequently Asked Questions
How accurate are the results?
The Framingham Risk Score applies a standard formula to your inputs — accuracy depends on how precisely you measure those inputs. For planning and estimation, results are reliable. For high-stakes or professional decisions, cross-check the output with a domain expert or primary source.
How do I know if my result is in a healthy range?
Reference ranges are provided above or in the calculator's output. These represent population averages — your optimal value may differ based on age, sex, ethnicity, and individual physiology. Use the result as a starting point for a conversation with your healthcare provider.
What is the Framingham Risk Score?
The Framingham Risk Score (FRS) is a validated cardiovascular risk prediction tool that estimates an individual's 10-year probability of developing major cardiovascular disease (CVD) — specifically coronary heart disease (CHD), including heart attack, angina, and coronary death. Origin: the Framingham Heart Study, started in 1948 in Framingham, Massachusetts, is one of the longest-running cardiovascular cohort studies in history. Researchers followed thousands of residents over decades, identifying the key risk factors for CVD. The original score was developed from this data. What the FRS calculates: Probability of major cardiovascular events (heart attack, stroke, CVD death) in the next 10 years, expressed as a percentage. Inputs include: Age and sex. Total cholesterol and HDL cholesterol. Systolic blood pressure and whether it's treated. Smoking status (current smoker). Diabetes status. Limitations: The original Framingham population (predominantly white, middle-class Americans) may not accurately predict risk in other ethnic groups. The score may underestimate risk in South Asians, African Americans, and other groups. The ACC/AHA Pooled Cohort Equations (2013) were developed to address some of these limitations and are now widely used alongside or instead of FRS. How it's used: Primary care physicians use it to guide discussions about statin therapy, lifestyle changes, and follow-up. A 10-year risk > 7.5–10% generally triggers a statin therapy discussion per current guidelines. Not a diagnosis — it's a probability estimate for population-level risk applied to an individual.
What is considered a high Framingham risk score?
The Framingham Risk Score is interpreted in categories that guide clinical decision-making. Risk categories (10-year CVD event probability): Low risk: < 5%. Typical treatment: lifestyle counseling, reassess in 4–6 years. Borderline risk: 5–7.4%. Lifestyle modification emphasis; statin usually not recommended unless other factors present. Intermediate risk: 7.5–20%. This is the most clinically important range — it's where shared decision-making about statin therapy occurs. Per ACC/AHA 2018 guidelines, ≥7.5% 10-year risk is the threshold for considering statin therapy. High risk: > 20%. Statin therapy strongly recommended; may also discuss blood pressure medication, lifestyle intervention. Very high risk (clinical ASCVD): If you've already had a heart attack, stroke, or are diagnosed with coronary artery disease, you're automatically considered very high risk — Framingham score isn't needed. Note: these thresholds vary by guideline source. European guidelines (SCORE) use different thresholds. Many cardiologists use 10% as the practical statin threshold in primary prevention. "Enhancers" that modify the decision: Even with intermediate risk, the decision to start statins is influenced by: Coronary artery calcium (CAC) score > 100. High-sensitivity CRP (hsCRP) > 2.0 mg/L. ABI (ankle-brachial index) < 0.9. Family history of premature CVD. Metabolic syndrome. These factors can "upclassify" someone from borderline to intermediate risk.
What are the main risk factors in the Framingham Risk Score?
The Framingham Risk Score uses seven primary inputs. Understanding each one helps you take targeted action. 1. Age: the strongest predictor. Risk approximately doubles with each decade after 45. Men ≥ 45 and women ≥ 55 are at substantially higher risk. 2. Sex: men are generally at higher baseline CVD risk than women until women reach menopause. Post-menopausal women catch up and often surpass men. 3. Total cholesterol: higher = higher risk. Target < 200 mg/dL. 4. HDL (High-Density Lipoprotein) — "good cholesterol": Higher is protective. HDL ≥ 60 mg/dL lowers your score (protective factor). HDL < 40 mg/dL (men) or < 50 mg/dL (women) increases risk significantly. 5. Systolic blood pressure (and whether it's treated): elevated systolic pressure damages arterial walls over time. Treated vs. untreated hypertension are scored differently — treated is slightly better even at the same number. 6. Smoking: current smoking approximately doubles CVD risk. Former smokers (quit >1 year): risk decreases substantially. 7. Diabetes: approximately doubles CVD risk. Women with diabetes have a particularly high relative risk increase. Which factors you can change: Modifiable: cholesterol (diet, statins, exercise), blood pressure (medication, diet, exercise, sodium reduction), smoking (cessation), diabetes (diet, medication, weight), and indirectly age risk (slowing biological aging through lifestyle). Not modifiable: actual age, sex, and family history. The good news: modifying even one major risk factor — especially smoking cessation or significant blood pressure reduction — can dramatically lower 10-year risk.
How can I reduce my Framingham cardiovascular risk?
Your 10-year cardiovascular risk is not fixed — lifestyle changes and medical treatment can significantly reduce it. Biggest impact interventions: 1. Quit smoking: single most impactful change. CVD risk begins dropping within months of quitting. After 1 year: risk is ~50% of a current smoker's. After 3–5 years: approaches non-smoker levels. 2. Treat hypertension: reducing systolic BP by 10 mmHg reduces CVD events ~17% (major meta-analyses). First-line: DASH diet, sodium restriction (<2,300 mg/day), exercise. Medication if lifestyle insufficient. 3. Improve cholesterol profile: LDL reduction: each 38 mg/dL (1 mmol/L) reduction in LDL → ~22% reduction in major cardiovascular events (CTT meta-analysis). Statins: most evidence-based LDL-lowering medication. Lifestyle: reduce saturated fat, increase fiber, add plant sterols, exercise. 4. Control blood sugar: diabetes prevention is possible — the Diabetes Prevention Program showed 58% risk reduction with moderate lifestyle change (5% weight loss + 150 min/week walking). 5. Exercise: 150 minutes/week of moderate-intensity aerobic exercise (brisk walking) reduces CVD risk ~14%. Each additional 1,000 steps/day reduces mortality risk ~6–10% (up to a plateau). 6. Healthy weight: obesity (BMI ≥ 30) increases risk through hypertension, diabetes, and dyslipidemia. 5–10% weight loss can improve all metabolic risk factors. 7. Heart-healthy diet: Mediterranean diet reduces CVD events by ~30% in high-risk individuals (PREDIMED trial). DASH diet reduces blood pressure. Timeline: meaningful risk factor improvements are typically visible within 3–6 months of consistent lifestyle change. Full Framingham score recalculation is typically done every 4–6 years in primary care (more frequently if risk factors are elevated).